Application of 3d qsar and docking studies in optimization of perylene diimides as anti cancer agent CN Hemalatha, VA Muthkumar Indian J. Pharm. Educ. Res 52 (4), 666-675, 2018 | 13 | 2018 |
A Comprehensive Review on the Role of Tau Proteins in Alzheimer's Pathology MV Aanandhi, A Niventhi, T Rujaswini, CN Hemalatha, D Praveen Research Journal of Pharmacy and Technology 11 (2), 788-790, 2018 | 11 | 2018 |
Virtual screening studies to design dual inhibitors of integrase and caspase; QSAR, Pharmacophore modeling and docking studies. SG Vijey Aanandhi Muthukumar, Hemalatha Catna Nagaraj, Debojit Bhattacherjee International Journal of Pharmacy and Pharmaceutical Sciences 5 (3), 95-102., 2013 | 8* | 2013 |
Insilico approach of interaction studies in Bacopa monnieri compounds targeting multi-proteins for Alzheimer's Disease SL Kanthamma, J Kriszhnamurthi, CN Hemalathaa, MV Aanandhi Research Journal of Pharmacy and Technology 11 (4), 1522-1526, 2018 | 5 | 2018 |
G-QUADRUPLEX LIGANDS AS STABILIZER TARGETING TELOMERASE ENZYME AS ANTI CANCER AGENTS MVA C N Hemalatha Asian Journal of Pharmaceutical and Clinical Research 10 (8), 50-53, 2017 | 5 | 2017 |
Evaluation of anti-cancer and anti-oxidant activity of Cissus quandrangularis extracts in DMBA induced mammary carcinomas CN Hemalatha, K Anbarasu, VM Aanandhi Research Journal of Pharmacy and Technology 10 (1), 293-300, 2017 | 5 | 2017 |
G-Quadruplex Ligands as Stabilizer targeting Telomerase as Anti-Cancer Agents MVA C N Hemalatha Mother Therasa Post Graduate and Research Institute of Helalth Sciences …, 2016 | 5* | 2016 |
Evalution and Molecular Docking of Benzimidazole and its Derivatives as a Potent Antibacterial Agent K Chandrasekar, B Kumar, A Saravanan, A Victor, S Sivaraj, M Haridoss Biomedical and Pharmacology Journal 12 (04), 1835-1847, 2019 | 4 | 2019 |
RP-HPLC method development and validation for the estimation of Midostaurin in bulk and pharmaceutical dosage form H Narayanaswamy, S Gejalakshmi, CN Hemalatha, V Pavankumar International Journal of Research in Pharmaceutical Sciences 11 (2020), 5108 …, 2020 | 3 | 2020 |
3D QSAR AND DOCKING STUDY OF PERYLENE-DI IMIDES ANALOGUES AS POTENT APOPTOSIS INDUCER AND EFFICACIOUS ANTICANCER AGENT. CN Hemalatha, AM Vijey Indian Drugs 54 (12), 2017 | 3 | 2017 |
Synthesis characterization and biological evaluation of Isoxazole and pyrazole derivatives from β- di ketones. SP Vijey Aanandhi Muthukumar, Sujatha Ramasamy, Sharmila Alladi, Hemalatha ... Journal of Pharmacy Research 4 (November 12, 2011,), 2011 | 3 | 2011 |
Synthesis of some novel perylene di imides and evaluation of their anti cancer activity C Hemalatha, M Vijey Aanandhi Asian J Pharm Clin Res 11, 1-9, 2018 | 2 | 2018 |
Virtual screening studies of two closely related withanolides to control cell proliferation and induction of cell senescence S Rashmi, S Nivethitha, CN Hemalatha, MV Aanandhi Rasayan J Chem 11 (1), 339-44, 2018 | 1 | 2018 |
Formulation & Characterization of Nanoparticles Loaded Cefadroxil. VM Hemalatha C N, YeswanthPrasannaKumar Research Journal of Pharmacy and Technology 10 (Issue 1), 2016 | 1* | 2016 |
Comparative of Antioxidant property of Actinidia Deliciosa extracts by DPPH Assay CN Hemalatha Research Journal of Pharmacy and Technology 17 (3), 1246-1249, 2024 | | 2024 |
In-silico ANALYSIS AND MOLECULAR DOCKING STUDIES OF NOVEL THIAZOLIDINEDIONE DERIVATIVES AGAINST PPAR-γ B Geetha, N Harikrishnan, P Sharmili, EE Rani, A Haripriya, ... Rasayan Journal of Chemistry 15 (2), 2022 | | 2022 |
Targeting Telomeric G-Quadruplex Complex by Perylene Diimides for Anticancer Activity: An In-Silico Study. H CN Current Trends in Biotechnology & Pharmacy, 2020 | | 2020 |
Methods of induction of Alzheimer's disease in rat and mice. CN Hemalatha, S Dhanalakshmi, S Indumathi, D Pavithra, N Harikrishnan Drug Invention Today 14 (3), 2020 | | 2020 |
Reimposing of marketed drugs in treatment of COVID 19 by insilicomethods CN Hemalatha, B Hemamalini, N Harikrishnan International Journal of Pharmaceutical Research, 2714-2719, 2020 | | 2020 |
Role of Histone Deacetylase (HDAC) Inhibitors for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) CN Hemalatha, N Janani, S Vanishree, N Harikrishnan Research Journal of Pharmacy and Technology 13 (6), 2963-2965, 2020 | | 2020 |